ARDS NEWS why is Aridis Pharmaceuticals Inc. price falling or rising
ARDS NEWS reasons for why stock price of Aridis Pharmaceuticals Inc. is falling or rising
ARDS Aridis Pharmaceuticals is falling or rising technical reasons
Technical analysis forecast of Aridis Pharmaceuticals Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Aridis Pharmaceuticals ARDS at this time. Stock is rising and might rise more.
It appears as if Aridis Pharmaceuticals ARDS gave a large move recently.
Stock of Aridis Pharmaceuticals (ARDS) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.
My analysis of Aridis Pharmaceuticals is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if Aridis Pharmaceuticals stays above 0.3, but if it comes below 0.3, then a intra day sell could be more profitable.
If you take a sell trade below 0.3, then use 0.3 as stoploss and 0.27 as target. However if you take a buy trade in Aridis Pharmaceuticals, then use 0.3 as stoploss and 0.4 as target.
ARDS Aridis Pharmaceuticals is falling or rising NEWS fundamental reasons
Sula Vineyards promoter holding rises to 24.5%, first purchase since IPO in 2022. Check details Promoter activity returned at Sula Vineyards as Rajeev Suresh Samant lifted his stake to 24.5%—the first increase since the 2022 IPO. The move comes despite weak Q3 numbers, with profits hit by tactical destocking in Karnataka and softer demand in Bengalu - NEWS as on 2026-02-18 indiatimes.com
Aker BP Awards Long-Term MMO Contract To Aker Solutions (RTTNews) - Aker BP ASA (AKRBF, AKRBP.OL), a Norwegian oil and gas exploration and production company, on Monday awarded a long-term Maintenance, Modification and Operation contract to Aker Solutions ASA (AKRTF, AKSO.OL) covering all Aker BP-operated asset - NEWS as on 2026-02-16 nasdaq.com
B J Duplex Boards reports standalone net loss of Rs 0.28 crore in the December 2025 quarter Reported sales nil - NEWS as on 2026-02-12 business-standard.com
More announcements and NEWS
ARDS Aridis Pharmaceuticals Inc. current price & indicator signals
Recent prices of ARDS Aridis Pharmaceuticals Inc. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 18 Tue Jul 2023 | 0.31 | 0.26 to 0.33 | 19.23% | 7.91 times |
| 17 Mon Jul 2023 | 0.26 | 0.25 to 0.32 | -18.75% | 3.37 times |
| 14 Fri Jul 2023 | 0.32 | 0.31 to 0.35 | -8.57% | 0.13 times |
| 13 Thu Jul 2023 | 0.35 | 0.28 to 0.38 | 2.94% | 0.59 times |
| 12 Wed Jul 2023 | 0.34 | 0.32 to 0.41 | 25.93% | 5.57 times |
| 11 Tue Jul 2023 | 0.27 | 0.25 to 0.27 | 3.85% | 0.05 times |
| 10 Mon Jul 2023 | 0.26 | 0.24 to 0.27 | 4% | 0.07 times |
| 07 Fri Jul 2023 | 0.25 | 0.23 to 0.26 | 8.7% | 0.07 times |
| 06 Thu Jul 2023 | 0.23 | 0.22 to 0.23 | 0% | 0.03 times |
| 05 Wed Jul 2023 | 0.23 | 0.22 to 0.24 | 0% | 0.03 times |
| 03 Mon Jul 2023 | 0.23 | 0.22 to 0.23 | 4.55% | 0.08 times |
| 30 Fri Jun 2023 | 0.22 | 0.20 to 0.22 | 0% | 0.1 times |
Videos related to: ARDS NEWS why is Aridis Pharmaceuticals Inc. price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


